- Novadaq Technologies Inc. NVDQ shares surged 95 percent to $11.70 after the company agreed to be purchased by Stryker Corporation SYK for $11.75 per share in cash.
- Clovis Oncology Inc CLVS shares climbed 43.7 percent to $86.17 after the company released encouraging late-stage data from an ongoing trial called ARIEL3. Top-line data from the phase 3 ARIEL3 trial successfully achieved its primary endpoint of improved progression-free survival in each of the three populations studied, Clovis stated. Moreover, PFS was also improved among the rucaparib group compared with placebo by blinded independent central review, a key secondary endpoint. Chardan Capital upgraded Clovis Oncology from Sell to Neutral.
- Rice Energy Inc RICE shares jumped 25.4 percent to $24.58 as EQT Corporation EQT announced plans to buy the company for $6.7 billion.
- Adomani Inc ADOM shares gained 13.3 percent to $10.88.
- Rigel Pharmaceuticals, Inc. RIGL surged 10.4 percent to $2.76 after the company disclosed that its New Drug Application for TAVALISSE is accepted by the FDA.
- Bellicum Pharmaceuticals Inc BLCM shares climbed 9.4 percent to $12.40.
- CAI International Inc CAI shares surged 9.1 percent to $22.89 after the company reported an expansion of its revolving credit facility. CAI also expects Q2 earnings of $0.55 to $0.58 per share.
- Cobalt International Energy, Inc. CIE shares rose 8.6 percent to $3.39.
- Exelixis, Inc. EXEL shares gained 8 percent to $20.79. IRC has confirmed that cabozantinib has significantly improved progression-free survival compared to sunitinib.
- Key Energy Services, Inc. KEG shares climbed 7.9 percent to $16.85.
- JD.Com Inc(ADR) JD shares rose 5 percent to $40.07. JD.Com reported that transaction volume of "6.18" anniversary sales event rose over 50 percent in the first 18 days versus first 18 days in 2016.
- Valeant Pharmaceuticals Intl Inc VRX gained 4.8 percent to $13.26 after the company reported that John Paulson joined its board of directors.
- United States Steel Corporation X rose 4.1 percent to $20.97. Longbow Research upgraded United States Steel from Neutral to Buy.
- AK Steel Holding Corporation AKS shares surged 4 percent to $6.23. Longbow Research upgraded AK Steel from Neutral to Buy.
- Nucor Corporation NUE gained 3.4 percent to $56.75. Longbow Research upgraded Nucor from Neutral to Buy.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in